Tag: Clinical trials
Zydus’ Desidustat shows efficacy & safety in treating Hypoxia in hospitalized...
Novel mechanism of targeting ‘hypoxia’ through HIF-PH inhibitor was studied for the first time in Hospitalised Covid-19 Patients in Mexico. Study trial indicates that the use of Desidustat for 14 days reduced CRP between baseline and day 14 among hospitalised patients with COVID-19.........................
COVID-19 Vaccine Cocktail: AstraZeneca to use components of Russia’s Sputnik V...
AstraZeneca accepted the proposal by RDIF and the Gamaleya Center to use one of the two vectors of the Sputnik V vaccine in additional clinical trials of its own vaccine, which will commence before the end of this year...................
Zydus gets DCGI’s approval for phase III clinical trials of its...
According to the company, Pegylated Interferon alpha – 2b significantly increased viral reduction and reduced the need for supplemental oxygen in moderate COVID-19 patients........................
Russia’s Sputnik V vaccine shows 95% efficacy after 42 days, one...
Currently, 40,000 volunteers are taking part in Phase III double-blind, randomized, placebo-controlled clinical post-registration study of the Sputnik V vaccine in Russia. The vaccine will be available in the lyophilized (dry) which is stored at a temperature of +2 to +8 degrees celsius...................
Biological E begins clinical trials of its COVID-19 vaccine
The results of this clinical trial are expected to be available by February 2021..................
DCGI nod to Serum Institute for conducting human trials of Oxford...
The Drugs Controller General of India has given the Serum Institute of India a green light to conduct phase 2 and 3 human trials of the Oxford-AstraZeneca COVID-19 vaccine candidate in India..................
DBT supported & Zydus driven COVID 19 vaccine, ZyCoV-D begins phase...
Vaccine Discovery Programme supported by the Department of Biotechnology, Govt. of India under the National Biopharma Mission, implemented by BIRAC moves into clinical trials The study will assess the safety, tolerability and immunogenicity of the vaccine.................
IIIT Delhi develops Artificial Intelligence model to repurpose existing drugs for...
Indraprastha Institute of Information Technology (IIIT) Delhi, has worked on computational AI (Artificial Intelligence) model for drug repositioning in the treatment of COVID-19........................
COVID-19: NovaLead Pharma gets DCGI nod to conduct Phase 3 trial...
Pune based pioneer in the field of drug repurposing in India, NovaLead Pharma has received ‘in principle’ clinical trial permission with DCG(I) for its Repurposed Drug discovery to treat moderate COVID-19............................
COVID-19: Is BCG vaccine the savior we are looking for?
It has been suggested that the severity of COVID-19 is higher in countries that do not have a history of Bacillus Calmette–Guerin (BCG) vaccination programs. Clinical trials are underway to investigate the possibility that they confer some immunity to COVID-19.......................